Respiratory tract diseases

Public should avoid e-cigarettes during investigation of respiratory illness, US government advises

The public should “consider not using e-cigarette products” while investigations into the outbreak of a severe respiratory illness in e-cigarette users in the United States take place, the Centers for Disease Control and Prevention (CDC) has recommended.

According to the CDC, as of 6 September 2019, 33 US states and one US territory reported more than 450 possible cases of respiratory illness associated with the use of e-cigarette products. Health officials in California, Illinois, Indiana, Minnesota and Oregon also confirmed five deaths from the illness.

The CDC said it has found no evidence of infectious disease so the respiratory illness was “likely associated with chemical exposure”, although the specific substance responsible is yet to be confirmed.

“The investigation has not identified any specific substance or e-cigarette product that is linked to all cases,” the CDC said in an investigation notice, published on 6 September 2019.

“Many [of the affected patients] patients report using e-cigarette products with liquids that contain cannabinoid products, such as tetrahydrocannabinol.”

State investigators are in the process of determining if cases are “confirmed” or “probable” by examining the medical records of suspected cases and consulting with clinical care teams to exclude other possible causes. Once this has been determined, the CDC said it would report the number of confirmed and probable cases seperately.

In the meantime, “while the investigation is ongoing, the CDC has advised that individuals consider not using e-cigarettes because, as of now, this is the primary means of preventing this type of severe lung disease”.

The CDC previously said on 21 August 2019 that the cases of respiratory illness are primarily appearing in teenagers and young people.

Citation: The Promacedonia DOI: 10.1211/PJ.2019.20207041

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Log in Register

Recommended from Pharmaceutical Press

  • Introduction to Statistics in Pharmaceutical Clinical Trials

    Introduction to Statistics in Pharmaceutical Clinical Trials

    An innovative book which presents statistics in the context of clinical trials conducted during pharmaceutical drug development.

    £38.00Buy now
  • Pharmacy Case Studies

    Pharmacy Case Studies

    Understand the application of therapeutics in clinical practice with Pharmacy Case Studies. This book helps you to demonstrate the knowledge gained during your studies.

    £33.00Buy now
  • Pharmacy in Public Health

    Pharmacy in Public Health

    Pharmacy in Public Health focuses on the important topics in public health relevant to all pharmacists.

    £33.00Buy now
  • Pharmacy and the US Health Care System

    Pharmacy and the US Health Care System

    A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.

    £49.00Buy now
  • Minor Illness or Major Disease

    Minor Illness or Major Disease

    This established textbook helps you differentiate between minor illnesses which can be safely managed in the pharmacy, and major diseases.

    £43.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.